Switzerland· 54613003
VICKS Nasivin 0.025 %, solution pour pulvérisation nasale
A oxymetazoline product, registered in Switzerland by Procter & Gamble International Operations SA and dispensed under Swissmedic category D. The same ATC class is registered in 13 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Oxymetazoline is registered in 13 of 19 countries.
Countries holding a registration under ATC R01AA05 (oxymetazoline), each read from that country’s own register.
- This record: Switzerland
- 9 of them publish a price we can compare per daily dose
Oxymetazoline · ATC R01AA05
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Statesprice
The record
At a glance
- Manufacturer
- Procter & Gamble International Operations SA
- Country
- Switzerland (CH)
- ATC code
- R01AA05
- ATC class
- Oxymetazoline
- Defined daily dose
- 0.4 mg, N
- Swissmedic category
- D
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
58 interactions on record for oxymetazoline.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Oxymetazoline · interactions on record
58 records
- 7 severe
- 48 moderate
Most severe, free to view
- MethylergometrineG02AB01severe
- ErgometrineG02AB03severe
- DihydroergotamineN02CA01severe
- ErgotamineN02CA02severe
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under R01AA05
Oxymetazoline, as other registers publish it.
- United States12 Hour Nasal Decongestant Extra MoisturizingWinCo Foods LLC
- United States12 Hour Original Nasal DecongestantSheffield Pharmaceuticals LLC
- United States12 Hour Original Nasal DecongestantWinCo Foods LLC
- PolandAcatar CareUS Pharmacia Sp. z o.o.
- PolandAcatar Care KidsUS Pharmacia Sp. z o.o.
- PolandAcatar ControlUS Pharmacia Sp. z o.o.
- United StatesAfrinBayer HealthCare LLC.
- United StatesAfrinBayer HealthCare LLC.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e688ce95-0691-4490-8bbe-6ec326b4076b GET /v1/drugs/e688ce95-0691-4490-8bbe-6ec326b4076b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about oxymetazoline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.